Arotinolol (INN, marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers. It also acts as a β3 receptor agonist. A 1979 publication suggests arotinolol as having first been described in the scientific literature by Sumitomo Chemical as "β-adrenergic blocking, antiarrhythmic compound S-596".
{{Drugbox | Verifiedfields = changed | verifiedrevid = 457153102 | IUPAC_name = (RS)-5-(2-{[3-(tert-butylamino)-2-hydroxypropyl]sulfanyl}- 1,3-thiazol-4-yl)thiophene-2-carboxamide | image = Arotinolol.svg | image_class = skin-invert-image | width = 275px
| tradename = Almarl | Drugs.com = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Rx-only | routes_of_administration = Oral (tablets)
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).